<DOC>
	<DOCNO>NCT00998361</DOCNO>
	<brief_summary>This perspective multicentric study treatment patient age equal less 60 year submit allogeneic hematopoietic stem cell transplantation HLA compatible relate unrelated donor affect resistent refractory relapse autologous stem cell transplantation Ewing Sarcoma Soft tissue sarcoma benefit conventional therapy .</brief_summary>
	<brief_title>Hematopoietic Stem Cell Transplantation From Human Leukocyte Antigen ( HLA ) Compatible Donor Ewing Sarcomas Soft Tissues Sarcomas</brief_title>
	<detailed_description />
	<mesh_term>Sarcoma</mesh_term>
	<mesh_term>Sarcoma , Ewing</mesh_term>
	<criteria>Age 060 year . Performance status accord Karnofsky score &gt; 70 % Normal liver function Normal renal function Normal cardiac function Informed consent Availability HLA compatible Donor Absence least one inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>1 Month</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>Sarcoma</keyword>
	<keyword>allogeneic</keyword>
	<keyword>Hemopoietic stem cell transplant</keyword>
</DOC>